|
⚲
|
| Keyboard |
| Exton Michael
✚
|
|
|---|---|
| CIK # | 0002029249 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002029249] | |
| 4 | [0002029249] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lexicon Pharmaceuticals Inc | |
| Exton Michael |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Option exercise | 503,263 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-28 | Option exercise | 503,263 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-28 | Tax withheld | 204,831 | $1.47 | 301,102 |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2026-02-12 | Grant | 862,440 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 1,293,670 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-02-13 | Grant | 1,509,790 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 2,264,690 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2024-07-08 | Grant | 1,675,000 | $0.00 |